scispace - formally typeset
Y

Yinkang Duan

Researcher at Pennsylvania State University

Publications -  14
Citations -  881

Yinkang Duan is an academic researcher from Pennsylvania State University. The author has contributed to research in topics: Population & Cohort study. The author has an hindex of 11, co-authored 14 publications receiving 825 citations.

Papers
More filters
Journal ArticleDOI

Association of Higher Levels of Ambient Criteria Pollutants with Impaired Cardiac Autonomic Control: A Population-based Study

TL;DR: It is suggested that higher ambient pollutant concentrations are associated with lower cardiac autonomic control, especially among persons with existing CVD, and highlight a putative mechanism through which air pollution is associated with CVD.
Journal ArticleDOI

GIS Approaches for the Estimation of Residential-Level Ambient PM Concentrations

TL;DR: In this paper, the feasibility of large-scale kriging estimations of daily residential-level ambient particulate matter (PM) concentrations, perform and compare cross-validations of different Kriging models, and calculate SE of the estimations.
Journal ArticleDOI

Age-related macular degeneration is associated with incident myocardial infarction among elderly Americans.

TL;DR: AMD is associated with older age, female gender, being white, and having a history of MI, hypertension, and diabetes, and these findings suggest the possibility of shared common antecedents between MI and AMD.
Journal ArticleDOI

Association of criteria pollutants with plasma hemostatic/inflammatory markers: a population-based study

TL;DR: It is suggested that the hemostasis/inmflammation markers analyzed are associated adversely with environmentally relevant ambient pollutants, with the strongest associations in the upper range of the pollutant distributions, and in persons with a positive history of diabetes and CHD.
Journal ArticleDOI

Metabolic Syndrome Clusters and the Risk of Incident Stroke. The Atherosclerosis Risk in Communities (ARIC) Study

TL;DR: The data support the need to target metabolic syndrome, especially MetS, with these 2 highest risk components (elevated blood pressure or elevated fasting glucose) in the clusters.